Sign in Subscribe
Cancer

Probiotics Show Therapeutic Potential in Gastric Cancer and Colorectal Cancer

Strategic Insights

— 1 min read

Investigators at Southern Medical University have made new findings in gastric cancer, highlighting the application of probiotics and their metabolic byproducts in gastric cancer and colorectal cancer. According to recent population-based studies, gastrointestinal cancers such as gastric cancer and colorectal cancer are on the rise worldwide, making it essential to develop new therapies. Probiotics have been identified as a promising complementary and alternative treatment option, particularly in inhibiting the infection of Helicobacter pylori, a major pathogenesis mechanism of gastric cancer. Additionally, probiotics can regulate the gut microbiome, enhance gut barrier competence, and regulate the immunological network in colorectal cancer.

Key Takeaways:

  • Probiotics and their metabolic byproducts demonstrate significant therapeutic potential in gastric cancer and colorectal cancer.
  • The main treatment method for gastric cancer and colorectal cancer is surgical treatment, but due to a large number of recurrence cases, there is an urgent need to develop new therapies.
  • Probiotics can treat gastric cancer by inhibiting the infection of Helicobacter pylori and regulating the immune system.
  • For colorectal cancer, probiotics can treat it by regulating the gut microbiome, enhancing gut barrier competence and regulating the immunological network.
  • When using probiotics, attention should be paid to the control of dosage, the management of safety, and the monitoring of activity.
  • Probiotics are becoming increasingly popular as a complementary and alternative therapy for gastric cancer and colorectal cancer.
  • The research highlights the importance of further studies on the application of probiotics and their metabolic byproducts in gastrointestinal cancers.

Statistics:

  • The incidence rates of gastrointestinal cancers such as gastric cancer and colorectal cancer are on the rise worldwide.
  • Cancer is the second leading cause of death globally.
  • Gastrointestinal cancer is one of the most common types of cancer.

Sources:

  • Research Progress on the Application of Probiotics and Fermentation Products in Gastrointestinal Cancers. BIO Web of Conferences, 2025, 182():01007. (BIO Web of Conferences - http://www.bio-conferences.org).
  • Health & Medicine Week. July 25, 2025; p 4388.

Read more